
In late May 2026, the Office of the United States Trade Representative quietly published a notice that, on its surface, looked like the kind of bureaucratic paperwork most people scroll past without a second thought. The headline that followed in the business press was blunt: “U.S. Hits Vietnam With Third Probe as Trade Pressure Grows.”…

A window into how Washington is now buying American pharmaceutical capacity and what the Lebanon expansion tells us about the new U.S. industrial-policy architecture for pharma Eli Lilly is making another major investment in U.S. manufacturing, announcing plans to spend an additional $4.5 billion at two of its sites in Lebanon, Indiana. The headline figure…